Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Anosognosia and delusions in the diseased brain

UnaWireD

Why is the diseased human brain able to produce false beliefs that persist despite evidence to the contrary? Unawareness of neurological disturbances (anosognosia) and Delusions are examples of such false beliefs. Both have productive, narrative features. Both have been independently linked to processes involved in self-reflection, metamemory, and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 213 888
European Countries Involved

Aqueous Supramolecular Polymers and Peptide Conjugates in Reversible Systems

ASPIRE

Supramolecular polymers are of major interest in the field of self assembly with a promising outlook in areas of viscosity modification, compartmentalized architectures, bio-conjugates and drug-delivery applications. They are dynamic macromolecular materials prepared by simple mixing of relatively small components bearing complementary or self...

Funding Programme
Start Date
End Date
Total Funding
€ 1 700 000
European Countries Involved

ARTIFICIAL INTELLIGENCE BASED HEALTH, OPTIMISM, PURPOSE, AND ENDURANCE IN PALLIATIVE CARE FOR DEMENTIA

AI4HOPE

Dementia is caused by a range of illnesses and disorders that damage the brain either directly or indirectly. With the rise of the ageing population in the EU, dementia is becoming a serious problem. Digital health interventions have the potential to improve the accessibility and effectiveness of palliative care. Palliative care is an area where...

Funding Programme
Start Date
End Date
Total Funding
€ 6 419 025

Artificial Intelligence for early and accurate neuropsychiatric diagnosis

NeuroPsyCAD

NeuroPsyCAD is a cloud-based reporting service that provides an accurate and early diagnosis of neuropsychiatric disorders. To achieve high accuracies, NeuroPsyCAD statistically compares a brain scan of a patient with a normative, human, and population representative database using machine-learning algorithms. It also analyses the brain as a whole...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action

SA-VOIR

Glaucoma is the world's leading cause of irreverisble blindness, affecting 20 million people in Europe and the US. Known as the Alzheimer’s of the eye, glaucoma is a neurodegenerative disorder that causes deterioration in peripheral vision. Affected patients report ‘seeing through a black tunnel’. Treatments to halt vision loss are available...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Assessing transcriptional and nuclear pore aging in age-equivalent and rejuvenated induced neurons from Alzheimer patients

iNtoPoreAge

I am a stem cell biologist specialized on modeling human neurodegenerative diseases. During my PhD with Dr. O. Brüstle (University of Bonn), I was trained in human stem cell and reprogramming technologies working on human models for Alzheimer’s Disease (AD). As a postdoc at the Salk Institute with Dr. F. H. Gage, I acquired and strong foundation in...

Funding Programme
Start Date
End Date
Total Funding
€ 178 157
European Countries Involved

Association of air pollution with dementia risk: is it confounded and mediated by environmental tobacco smoke and consumption of fish?

DEMAIRPO

Air pollution (AP) remains prevalent globally. Its impact on dementia risk is unclear. We propose to investigate the association of dementia with AP and explore mediation effects on the association from other factors. We will examine data of 2776 participants aged >=60 years who were randomly recruited from urban and rural of China. Their baseline...

Funding Programme
Start Date
End Date
Total Funding
€ 195 455
European Countries Involved

Attempts to Control the End of Life in People with Dementia: Two-level Approach to Examine Controversies

CONT-END

In dementia at the end of life, cognitive and physical decline imply that control is typically lost. CONT-END will examine control in the context of three emerging interventions which contain a controversial element of striving for control in the process of dying with dementia: advance care planning of the end of life, use of new technology to...

Funding Programme
Start Date
End Date
Total Funding
€ 1 988 972
European Countries Involved

BEHAVIOUR PATTERN BASED ASSISTANT FOR THE EARLY DETECTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES

BEDMOND

The BEDMOND project aims at developing an ICT-based system for an early detection of  Alzheimer’s disease and other neurodegenerative diseases, based on a behavioural change to approach and focused in elderly people while living at home in an Ambient Assisted Living  environment. With such an early detection health professionals can later on apply...

Funding Programme
Start Date
End Date
Total Funding
€ 2 379 179
European Countries Involved

Bendable Bioplatform for Electrically stimulated Neuronal Differentiation

BEND

With western countries aging faster, the neurodegenerative diseases like Parkinson’s, Alzheimer’s, Huntington’s etc. pose serious threat to quality of life, especially for people over 65 years[1]. In Europe, number of people suffering with dementia, which results from neuronal degeneration, is on the rise it is expected to be double in the next 20...

Funding Programme
Start Date
End Date
Total Funding
€ 195 455
European Countries Involved

Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health

BNCI2

More than 1 billion people worldwide suffer from compromised mental health due to a brain disorder, such as depression, addiction, obsessive-compulsive disorder (OCD) or dementia. While already accounting for 19% of all years lived with disability, the relative share of these disorders is further increasing. Currently, due to the complexity of the...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 875
European Countries Involved

Bidirectional remote deep brain control with magnetic anisotropic nanomaterials

BRAINMASTER

The emergence of a new era in neuromodulation is led by the intriguing potential of functional materials to replace or control neural activity. The ability to simultaneously analyse neural activity offers the potential to translate signals into a feedback loop for intuitive therapy or even to replace lost neurological functions. However...

Funding Programme
Start Date
End Date
Total Funding
€ 1 500 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).